Group One Trading’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-228,910
| Closed | -$874K | – | 7680 |
|
|
2024
Q1 | $989K | Sell |
228,910
-292,417
| -56% | -$1.02M | ﹤0.01% | 2098 |
|
|
2023
Q4 | $1.59M | Buy |
521,327
+474,516
| +1,014% | +$892K | ﹤0.01% | 2060 |
|
|
2023
Q3 | $67.4K | Buy |
46,811
+45,741
| +4,275% | +$88.5K | ﹤0.01% | 4823 |
|
|
2023
Q2 | $2.66K | Sell |
1,070
-1,288
| -55% | -$3.52K | ﹤0.01% | 6994 |
|
|
2023
Q1 | $6.32K | Sell |
2,358
-5,176
| -69% | -$24.9K | ﹤0.01% | 6182 |
|
|
2022
Q4 | $40.9K | Buy |
7,534
+3,562
| +90% | +$29.9K | ﹤0.01% | 5146 |
|
|
2022
Q3 | $50K | Buy |
3,972
+544
| +16% | +$6.21K | ﹤0.01% | 5409 |
|
|
2022
Q2 | $17K | Sell |
3,428
-19,489
| -85% | -$108K | ﹤0.01% | 6427 |
|
|
2022
Q1 | $174K | Buy |
+22,917
| New | +$217K | ﹤0.01% | 4948 |
|
|
2021
Q1 | – | Sell |
-7,524
| Closed | -$175K | – | 8135 |
|
|
2020
Q4 | $135K | Buy |
7,524
+2,524
| +50% | +$37.7K | ﹤0.01% | 4345 |
|
|
2020
Q3 | $58K | Buy |
+5,000
| New | +$82.5K | ﹤0.01% | 4551 |
|
|
2020
Q1 | – | Sell |
-465
| Closed | -$12K | – | 5860 |
|
|
2019
Q4 | $12K | Buy |
+465
| New | +$10.9K | ﹤0.01% | 4555 |
|
Group One Trading's GTHX Position: Q2 2024 in Review
Group One Trading sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2024, closing a stake of 228,910 shares — an estimated $874K sold.
Group One Trading first reported a position in GTHX in Q4 2019 and held it in 12 quarters. The position peaked at $1.59M in Q4 2023. 88 funds tracked by Wall St. Rank hold GTHX as of Q2 2024.
- Group One Trading reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Group One Trading sold 228,910 G1 Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $874K.
- Group One Trading first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2019 and held it in 12 quarters.
- Group One Trading's G1 Therapeutics, Inc. Common Stock position peaked at $1.59M in Q4 2023.
- 88 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2024.
Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.